Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30

D-0289-2019

November 30, 2018

Class III

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 81703
Status
Terminated
Classification
Class III
Quantity
4464 bottles
Official record key
drug-enforcement:D-0289-2019

Official wording

Reason: Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).

Code information: Lot#: OWSA18002-A, Exp 7/2020

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).